Perth, Western Australia, October 23, 2007 Australian drug discovery and development company Phylogica (ASX:PYC) has announced that its lead drug candidate for burns, PYC35B will progress to human trials in 2008.
This is clinical!
Once this trial shows that it works on humans , it is going to be blue sky for sure. With there hits on things like Asthma, athritis, heart disease, brain trauma and more. ...
Well dont take my word , check out their last quaterly ann. Oh they have nearly $7 mill in the bank and getting more grants nearly every second week for different leads.
Cheers Ag.
Yes i hold... long
What are your motives for posting rubbish if you have no stock ?
Ag
PYC Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)